Vol 7, No 1 (February 2018): Translational Andrology and Urology (Prostate Cancer Screening and Active Surveillance in the Western World)

Original Article

What is an acceptable false negative rate in the detection of prostate cancer?
Jan F. M. Verbeek, Monique J. Roobol, the ERSPC Rotterdam study group

Review Article

Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices
Netty Kinsella, Jozien Helleman, Sophie Bruinsma, Sigrid Carlsson, Declan Cahill, Christian Brown, Mieke Van Hemelrijck

Original Article

Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study
Frank-Jan H. Drost, Antti Rannikko, Riccardo Valdagni, Tom Pickles, Yoshiyuki Kakehi, Sebastiaan Remmers, Henk G. van der Poel, Chris H. Bangma, Monique J. Roobol, for the PRIAS study group

Review Article

Active surveillance: a review of risk-based, dynamic monitoring
Daan Nieboer, Anirudh Tomer, Dimitris Rizopoulos, Monique J. Roobol, Ewout W. Steyerberg
Magnetic resonance imaging in active surveillance—a modern approach
Francesco Giganti, Caroline M. Moore

Original Article

Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSAdensity, with different thresholds for significant disease
Ivo G. Schoots, Daniel F. Osses, Frank-Jan H. Drost, Jan F. M. Verbeek, Sebastiaan Remmers, Geert J. L. H. van Leenders, Chris H. Bangma, Monique J. Roobol